4
Changes in Ownership
Axogen, Inc. Filed Acc 0001179110-20-012059
VP, Clinical&Translational Sc gave up 4,373 shares (to pay taxes)
- VP, Clinical&Translational Sc acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-12-15 | Option exercise | +15,000 | $4.81 | $72,150 | 66,056 | D |
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-12-15 | Shares withheld for taxes | −4,373 | $16.50 | $72,155 | 61,683 | D |
| Derivatives | |||||||
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-12-15 | Option exercise · Employee Stock Option (right to buy) | −15,000 | 0 | D | ||
Loading xslF345X03/edgar.xml…